Aims/hypothesis. Insulin resistance is considered to be a risk factor for diabetes and coronary heart disease and is determined by the interaction between genetic and environmental factors. The SstI polymorphism in the apolipoprotein C-III gene has been related to the presence of different features of the insulin resistance syndrome. We investigate if this mutation influences the peripheral effect of insulin in healthy young subjects (30 men and 29 women) eating a westernised diet. Methods. We investigated peripheral insulin sensitivity with the insulin suppression test after a 28-day westernised high-saturated fat diet (38% total fat and 18% saturated fat with 115 mg of cholesterol per 1000 Ju). Results. Steady state plasma glucose values were lower in S1-S1 compared with S1-S2 men (p=0.018 by ANOVA), but not in women (p=0.723). Conclusion/interpretation. There was no difference between carriers and non-carriers of the S2 allele in relation to incidence and sensitivity; although on subgroup analysis there was an effect in men but not in women. [Diabetologia (2002[Diabetologia ( ) 45:1196[Diabetologia ( -1200 Keywords High-saturated fat diet, insulin sensitivity, glucose metabolism, non-esterified fatty acids. 
Type II (non-insulin-dependent) diabetes mellitus by decades. In most cases, the clinical expression of the disease can be prevented by dietary and lifestyle modification [1] . On the other hand, the genetic base of Type II diabetes is very heterogeneous and has been related to various genetic mutations that codify proteins linked to glucose and insulin metabolism, such as the insulin receptor [2] , the insulin receptor substrate-1 [3] , the Rad protein [4] , the glycogen synthase [5] and the β-3-adrenergic receptor [6] . However, the genetic background of insulin resistance and Type II diabetes is more complex and it can also involve other genes seemingly unrelated to carbohydrate metabolism.
Apo C-III is an important component of lipoprotein metabolism and is involved in the delipidation of triglyceride rich particles [7, 8] . The S2 allele, identified by the restriction enzyme Sst-I, is in disequilibrium with two mutations located in the promoter region of the apo C-III gene [9] . The presence of this polymorphism has been associated with clinical and biochemical characteristics of the insulin-resistance state [10] , Insulin resistance is considered to be a risk factor for both diabetes and coronary heart disease and is determined by the interaction between genetic and environmental factors. In general, high intake of dietary fat has been associated with obesity and its co-morbid conditions, including heart disease and diabetes. All of these factors are related to the global process of the "westernisation" of lifestyles and dietary habits, especially the high intake of calories from saturated fat. Insulin resistance usually precedes the diagnosis of including an increase in insulin plasma concentrations after an oral-glucose-tolerance test in healthy men [11] . Our aim is to investigate the influence of the Sst-I polymorphism in the apo C-III gene on insulin sensitivity in healthy young men and women after they ingest a westernised diet enriched in saturated fat.
Subjects and methods
Subjects and diets. Fifty-nine healthy normolipemic (total plasma cholesterol concentrations lower than 5.3 mmol/l) subjects (30 men and 29 women) attending the University of Cordoba volunteered to participate in the study. The subjects were selected from among 300 hundred healthy young men and women; 37 had the genotype S1-S1 (16 men and 21 women) and 22 had the genotype S1-S2 (14 men and 8 women). All subjects gave their informed consent according to the Declaration of Helsinki as revised in 1996. All underwent a comprehensive medical history, a physical examination and clinical chemistry analyses before enrolment. Subjects were younger than 30 years of age (mean age 23.1±1.8 SD) and showed no evidence of any chronic illness (hepatic, renal, thyroid, or cardiac dysfunction) or unusually high levels of physical activity.
Dietary information, including alcohol consumption, was collected during 7 consecutive days. Individual energy requirements were calculated by taking into consideration subject's weight and physical activity. Subjects were encouraged to maintain their regular physical activity and lifestyle and were asked to record any event that could affect the outcome of the study, such as stress, change in smoking habits, and alcohol consumption or foods not included in the experimental design.
The study design included a 28-day period during which all the subjects consumed a high-saturated fat-enriched diet (SFA diet), with 15% of energy as protein, 47% as carbohydrates and 38% as fat (20% SFA fat, 12% monounsaturated fat and 6% polyunsaturated fat). The mean dietary cholesterol intake was 27 mg/MJ. A glucose suppression test was carried out at the end of the dietary intervention. The Human Investigation Review Committee at the Reina Sofia University Hospital approved the study.
The composition of the experimental diet was calculated using the United States Department of Agriculture (USDA) food tables [12] or the Spanish food composition tables for local foodstuffs [13] . Fourteen menus, prepared with regular solid foods, were rotated during the experimental period. Palm oil and butter was used to provide SFA fat. Lunch and dinner were consumed in the hospital dining room, whereas breakfast and an afternoon coffee break were taken in the medical school cafeteria. A dietician supervised all meals. Duplicate samples from each menu were collected, homogenized, and stored at -80°C. Protein, fat and CHO content of the diet were analysed using standard methods [14] .
Blood sampling and biochemical determinations. Venous blood samples for glucose, lipid and lipoprotein analysis were collected in EDTA containing tubes from subjects after a 12-h overnight fast. Cholesterol and triglycerides were assayed by enzymatic procedures. HDL-cholesterol was measured by analysing the supernatant obtained after precipitation of a plasma aliquot with extra sulphate-Mg 2+ . The LDL-cholesterol concentration was calculated from the total cholesterol, triglycerides, and HDL-cholesterol values using the Friedewald formula [15] . Non-esterified free fatty acid concentrations were analysed by an enzymatic colorimetric assay (Boehringer Mannheim, Mannheim, Germany) [16] . To reduce interassay variation, plasma for biochemical determinations were stored at -80°C and analysed in duplicate at the end of the study.
Glucose suppression test.
A modified insulin suppression test [17, 18] was carried out on all the subjects at the end of the dietary period. The study began at 8:00 am, after 12 h of fasting. A continuous infusion of somatostatin (214 nmol/h), insulin (180 pmol·m -2 ·min -1 ) and glucose (13.2 mmol·m -2 ·min -1 ) were infused in the same vein. Somatostatin was used to inhibit endogenous insulin secretion. Blood was sampled every 30 min for the first 2.5 h, by which time steady-state plasma glucose (SSPG) and steady-state plasma insulin (SSPI) concentrations were achieved. Blood was then sampled at 10-min intervals for the last 30 min (at minutes 150, 160, 170 and 180) for measurement of plasma glucose and insulin concentrations. These four values determined the SSPG and SSPI concentrations. Since SSPI concentrations were similar in all subjects, SSPG concentrations provided a measure of the ability of insulin to promote the disposal of infused glucose. Subjects with high SSPG are relatively more insulin resistant than others with lower SSPG.
Determination of the apo C-III genotype. DNA was extracted from 10 ml of peripheral venous blood in EDTA (1 mg/ml) containing tubes by the salting-out method. The apo C-III polymorphism was determined by PCR amplification of a fragment of 428-bp of the apo C-III gene using 250 ng of genomic DNA, 0.2 µmol of nucleotides, 2.5 U of Taq polymerase (Promega, Madison, Wis., USA) and 1 µmol/l of each "primer" (CIII-1, 5′-GGTGACCGATGGCTTCAGTT-3′; CIII-2, 5′-CA-GAAGGTGGATAGAGCGCT-3′) in a final volume of 50 µl. DNA was denatured at 95°C for 5 min followed by 30 cycles of denaturation at 95°C a minute, "annealing" at 55°C for 2 min, and extension at 72°C for 1.5 min. Twenty µl of the PCR amplification products were digested with 10 units of Sst-1 restriction enzyme in a total volume of 35 µl. The products obtained were submitted to 8% non-denaturing polyacrylamide electrophoresis at 150 V for 2 h followed by silver staining.
Statistical analyses. Statistical analyses were carried out using the SPSS statistical package. ANOVA for repeated measures was used to analyse the differences between SSPG and SSPI concentrations among several study groups. When statistically significant effects were demonstrated, Tukey's post-hoc test was used to identify differences between groups. The KolmogorovSmirnov one-sample test was used to test the normality of the distribution. Variables that were not normally distributed were log-transformed before the analysis. A p value of less than 0.05 was considered significant. All data are presented in the text and tables as means ± SD.
Results
There were no significant differences between subjects with the S1S1 genotype (n=37) and those with the S1S2 genotype (n=22) for any of the lipid parameters, fasting glucose plasma concentrations or fasting NEFA after the SFA diet ( Table 1 ). The absence of significant differences in most parameters of the study was observed when we compared men and women with the different genotypes (Table 2) . However, fast-ing NEFA concentrations were higher during the high-SFA diet in S1-S2 men compared with S1-S1 men.
Insulin values during the SSPI period (means ± SD at minutes 150, 160, 170 and 180 of the insulin suppression test) were similar in S1-S1 men and women (mean values ± SD for the four samples were 9.5±2.8 and 9.8±2.3 mIU/ml, respectively), and S1-S2 men and women (mean values ± SD 9.8±2.2 and 9.4±2.8 mIU/ml, respectively). During the SSPG, no significant differences were observed between the S1-S1 and the S1-S2 subjects ( Fig. 1A; p=0.101 by ANOVA) or between the S1-S1 women compared with S1-S2 women ( Fig. 1B; p=0.723 ). These data indicate the absence of a polymorphism effect on the whole population and on the subgroup of women. However, the S2 allele in the apo C-III gene was associated with a relevant decrease in insulin sensitivity in men ( Fig. 1C; p=0.018 ).
Discussion
Our data indicate that the presence of the S2 allele of the Sst-I polymorphism in the apo C-III gene is associated with a decrease in peripheral insulin action assessed by the insulin suppression test in healthy men after ingesting a westernised diet. The same effect was not observed in women. The insulin suppression test was done at the end of the dietary period and not at the beginning; thus the possible effect of variation between subjects cannot be completely excluded. Currently, the mechanism by which this genetic variation can influence CHO metabolism is not known. Insulin acts upon the promoter of the apo C-III gene, reducing its expression and plasma concentrations of the apoprotein. In contrast, the S2 allele, identified by the restriction enzyme Sst-I, is in disequilibrium with two mutations located in the promoter region of the apo C-III gene [9] . The presence of these two mutations determines the absence of regulation by the insu- lin and the decrease of apo-CIII, which is physiologically produced by the hormone, resulting in an increase in plasma concentrations of apoprotein CIII [19] . Apo C-III modulates the metabolism of triglyceride rich particles [20] , so its overexpression could interfere in the plasmatic clearance of the triglyceride rich lipoproteins, resulting in its subsequent increase. Furthermore, it has been suggested that hypertriglyceridaemia and an SFA diet might favour insulin resistance [21, 22, 23] by increasing plasma concentrations of NEFA, which could inhibit glucose utilisation by peripheral cells and reduce the effect of peripheral insulin [24] .
In this study no significant associations between the S2 allele and plasma lipid variables in men and women were found. However, these findings were not supported by other investigators [25, 26] who found differences between and women in the association of Sst-I polymorphism with lipids. A study [27] described an increase of total cholesterol in both male and female carriers of the S2 allele, whereas an increase in plasma apo B levels and a trend toward lower HDL-C concentrations was noted only in S2 male carriers. Discrepancies with our results could be due to three factors: (i) the subjects in our study were young, healthy and normolipaemic; (ii) there were no hypercholesterolaemic or hypertriglyceridaemic subjects; (iii) the size of the sample was small and was calculated to study insulin resistance and not lipid parameters. Other studies [28, 29] carried out in isolated communities analysed men and women separately but they also failed to show any association of the allele with variations in the lipid profile.
In agreement with our results, another study [25] found that the S2 allele of the Sst-I polymorphism in the apo C-III gene was associated with increased fasting insulin concentrations in men but not in women. The lack of effect of the S2 allele on insulin sensitivity in females is similar to the phenomenon observed upon plasma lipids in response to changes in diet in the presence of different apo E polymorphisms [30] . This effect could be caused by a protective effect of the hormonal status to environmental changes [25] . Female hormones are thought to intervene by either inhibiting the greater expression of apo C-III derived from the presence of the S2 allele or by interfering in the release of NEFA to the plasma with a subsequent increase in glycaemia via the Randle cycle [31].
In conclusion, there was no difference between carriers and noncarriers of the S2 allele in relation to insulin sensitivity. However on subgroup analysis there was an effect in men, but not in women. This finding suggests that S2-S1 men have a high risk of developing insulin resistance syndrome and Type II diabetes mellitus under a high-saturated fat enriched diet. Therefore, a possible strategy for the prevention of cardiovascular disease would be to identify this population. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet i:785-789
